Bright Minds Biosciences (DRUG) Total Current Liabilities (2021 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Total Current Liabilities came in at $2.8 million in Q1 2026, up 528.6% YoY from $444609.0 in Q1 2025, and up 146.28% on a QoQ basis from $1.1 million in Q4 2025.
Bright Minds Biosciences (DRUG) Total Current Liabilities (2021 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 6 years of Total Current Liabilities data on file, last reported at $2.8 million in Q1 2026.
- Quarterly Total Current Liabilities rose 528.6% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 528.6% YoY) and the FY2025 annual result came in at $1.7 million, up 337.87% from the prior year.
- Total Current Liabilities rose to $2.8 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $2.8 million in Q1 2026 to a low of $209499.0 in Q3 2023.
- A 5-year average of $852827.6 and a median of $490603.7 in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities slumped 81.44% — and 2026, when it surged 528.6%.
- Tracing DRUG's Total Current Liabilities over 5 years: stood at $389049.9 in 2022, then slumped by 46.15% to $209499.0 in 2023, then surged by 57.7% to $330380.1 in 2024, then soared by 243.49% to $1.1 million in 2025, then surged by 146.28% to $2.8 million in 2026.
- The last three Total Current Liabilities figures came in at $2.8 million (Q1 2026), $1.1 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 436,629.57 |
| Mar 31, 2025 | 444,609.02 |
| Dec 31, 2024 | 330,380.13 |
| Sep 30, 2024 | 387,552.88 |
| Sep 30, 2023 | 209,499.05 |
| Jun 30, 2023 | 536,598.36 |
| Mar 31, 2023 | 743,977.73 |
| Dec 31, 2022 | 389,049.88 |
| Sep 30, 2022 | 1.13 Mn |
| Sep 30, 2021 | 507,288.34 |